|Articles|July 15, 2002
- BioPharm International-07-01-2002
- Volume 15
- Issue 7
Facilitating Client Audits: The Contract Laboratory Perspective
Author(s)Barbara Carter-Hamm, Gary Vinson
by Gary Vinson, and Barbara Carter-Hamm, Magellan Pharmaceutical Development Pharmaceutical companies rely on outsourcing organizations that anticipate and prepare for client audits. Such contractor companies become collaborative partners. A technically proficient contract organization understands client needs, knows the regulatory environment in which drug development takes place, and sees a client audit as a professional opportunity to show its expertise.
Advertisement
Articles in this issue
over 23 years ago
Knowledge Management: The Four Pillars of Successover 23 years ago
Inside Washington: One Hundred Years of Biotech Regulationover 23 years ago
Guest Editorial: Supreme Court Rules on FestoNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
AI, CRISPR, and mRNA Driving Biotech’s Smartest Decade Yet
2
Conjugation and Regulation Challenges for Advanced Molecules: Part Two of Three with Abzena
3
Top BP Videos of 2025: An Intersection of AI, Innovation, and Compliance
4
FAQ: Understanding Biosimilars, Biobetters, and Interchangeability
5
